| |
|
|
| Address |
223-23,SANGDAEWON 1-DONG, JUNGWON-GU,SEONGNAM-SI,GYEONGGI-DO |
| Home Page |
www.daewoongholdings.com
|
| Established |
1961. 1.10 |
Tel |
031-741-7700 |
| Listed |
1973. 6.26 |
IR |
02-550-8209 |
| Common shares O/S |
6,297,926 |
President |
Yun,Yeong Hwan/Jeong,Nan Yeong |
| Preferred shares O/S |
|
No.of Employees |
260(2008. 6) |
| Firm' operating income rose, due to sales growth deriving from growth in Allmetec and Urusa, flagship product of firm's subsidiary, Daewoong Pharmaceutical. Firm added Jeju Movie Land, operating museum biz and in charge of establishment of a subsidiary in Thailand of Dawwoong Pharmaceutical, into its affiliates. Firm maintains non-borrowings Mgt, and maintains stable level in terms of non-operating balance including interest income by investing in short-term financial products. |
|
  |
| Firm's performance is forecast to be maintained thanks to stable growth of Daewoong Pharmaceutical equipped with competitiveness as a large pharmaceutical company and pharmaceutical industry's features with little impacts deriving from biz cycle fluctuation. Firm's performance from new medication development is expected deriving from active investment in bio technology industry including BT sector on the government dimension. Firm is expected to show smooth cash flows, based on stable financial structure and cash creation ability. |
|
 |
(date: 2008.06, unit : %) |
| Name |
Daewoong Chemical |
Yoon Yeonghwan |
Yoon Jaeseung |
| Portion |
30.9 |
16.4 |
8.1 |
|
 |
(unit : %) |
| Sales |
Assessment Profit Of Actual Value Method |
47.2 |
Cost |
Raw Materials |
|
| Service Sale |
46.1 |
Labors |
|
| Fee |
3.5 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
00. 7 |
~02. 3 |
02.11 |
~03. 3 |
03.12 |
| Type |
BI |
CB |
CR |
CB |
RI |
| Amount |
25.00 |
31.62 |
- 246.96 |
2.07 |
95.71 |
|
|
|
|
